title: CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
authors.forename: L J C M
authors.initials: LJ
authors.lastname: van Zutven
authors.forename: E
authors.initials: E
authors.lastname: van Drunen
authors.forename: J M
authors.initials: JM
authors.lastname: de Bont
authors.forename: M M
authors.initials: MM
authors.lastname: Wattel
authors.forename: M L
authors.initials: ML
authors.lastname: Den Boer
authors.forename: R
authors.initials: R
authors.lastname: Pieters
authors.forename: A
authors.initials: A
authors.lastname: Hagemeijer
authors.forename: R M
authors.initials: RM
authors.lastname: Slater
authors.forename: H B
authors.initials: HB
authors.lastname: Beverloo
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D020732:Cytogenetic Analysis; D005260:Female; D017353:Gene Deletion; D019942:Genes, p16; D006801:Humans; D007223:Infant; D008297:Male; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000235:genetics*; D011237:Predictive Value of Tests; D011379:Prognosis